Pre-market Hot Trades in US Stocks

Bit Origin is down 7.09% in pre-market trading. Based on recent important news:

1. On July 21, Bit Origin announced the purchase of 40.54 million DOGE at an average price of $0.2466, marking the first operation in its digital asset treasury strategy, which raised concerns about its financial stability, leading to a 7.09% drop in stock price.

2. On July 22, CEO Jiang Jinghai stated that DOGE has great potential in small payment scenarios, which led to market doubts about its strategic direction, further exacerbating stock price volatility.

3. On July 22, Bit Origin announced it secured up to $500 million to support its DOGE treasury, raising market concerns about the efficiency of its capital usage, impacting the stock price.

Top Gainers in Pre-market US Stocks

Abivax SA is up 489.50% in pre-market trading. Based on recent important news:

1. On July 22, Abivax SA announced the postponement of its financial report for the first half of 2025, originally scheduled for August 11, now delayed to September 8. This news may raise market concerns about the company's financial condition, leading to significant stock price volatility.

2. On July 22, Abivax SA reported preliminary cash and cash equivalents of approximately $71.4 million or €61 million (unaudited) as of June 30, which may affect investors' judgment on the company's liquidity and financial health.

3. On July 22, the market assessed the potential impact of the delay in Abivax SA's financial report, resulting in a significant pre-market stock price increase.

Wang & Lee is up 104.96% in pre-market trading. Based on recent key news:

1. On May 21, during JP Morgan's Investor Day event, Jamie Dimon pointed out market complacency, with investors expecting continued market growth, driving Wang & Lee's stock price significantly higher.

2. On May 15, the small-cap style in the A-share market quickly recovered, with several small-cap funds rebounding sharply, boosting Wang & Lee's stock price.

3. On May 16, the CSI 2000 Enhanced ETF rose by 21.17%, with expectations of liquidity easing enhancing market risk appetite, benefiting Wang & Lee's rise.

Anebulo Pharmaceuticals is up 79.78% in pre-market trading. Based on recent important news:

1. On July 23, Anebulo Pharmaceuticals announced plans to terminate the registration of its common stock and approved a reverse stock split plan of 1 for 2500 to 1 for 7500. Shareholders will receive $3.50 per share, leading to a significant stock price increase.

2. On July 23, the company's board approved a privatization plan proposed by a special committee composed of independent directors, further driving up the stock price On July 23, Anebulo Pharmaceuticals, focused on developing innovative treatments for acute cannabis toxicity effects, saw an optimistic market outlook for its future development, driving the stock price up